sBiochemical markers of myocardial damage are together with the clinical hi
story, the physical examination and the 12-lead ECG key elements in the cli
nical evaluation of patients presenting with symptoms suggestive of an acut
e coronary syndrome (ACS). In this situation the detection of myocardial da
mage, even very minor, is of importance, not only for diagnosis, but also f
or risk assessment and selection of treatment. The new markers of myocardia
l damage, troponin T and I, have been shown to offer some advantages over t
he conventional markers in ACS and there is also an increasing interest for
troponins in other clinical situations, e.g. after surgery and percutaneou
s coronary intervention. This paper will discuss the role of troponins in t
hese different clinical situations.